This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Julie Campbell | |
---|---|
Born | Sydney | 2 November 1946
Nationality | Australian |
Alma mater |
|
Known for |
|
Awards |
|
Scientific career | |
Fields | Vascular Biology |
Institutions |
|
ProfessorJulie Hazel Campbell AO FAA is an Australian vascular biologist specialising in vascular smooth muscle. She is a professional fellow at the Australian Academy of Science [1] and holds two patents for vascular implant material. [2] Campbell made a groundbreaking discovery in the early 1970s, revealing that smooth muscle cells possess various phenotypes that regulate their biology and reaction to disease triggers, such as heart disease. Additionally, she uncovered methods to sustain these cells in a non-disease state. This newfound knowledge significantly advanced the comprehension of atherosclerotic plaque formation and offered valuable insights into potential preventive measures. [3]
Campbell has received recognition for her work in leading research into the development of blood vessels naturally within a patient, known as the "grow-your-own" arteries technique, a technique that improves the effectiveness of procedures such as heart bypass surgery. [4]
Campbell was born on 2 November 1946, [5] in Sydney, Australia. In the fourth grade, she was selected to attend an advanced class that was specifically reserved for high achievers. She attended St. George Girls High School and studied chemistry part-time at the University of New South Wales, while working at the Atomic Energy Commission.
Campbell intended to pursue a career in chemistry, but after taking her first biology course, Campbell became fascinated with the structure and activities of living cells, and went to study physiology instead of chemistry.
At the age of 22, Campbell married Gordon Ronald Campbell. [6] In 1975, both Campbell and her husband held the career position of postdoctoral research in the Department of Zoology at the University of Melbourne. In 1976, both Campbell and her husband followed their first Ph.D. supervisor, Burnstock, to the University College of London for a year to continue their postdoctoral research in the Department of Anatomy and Embryology. [7] In 1978, the couple went to the University of Iowa for nine months, before going to the University of Washington in Seattle to finish their postdoctoral research. [7] During this period of time, Campbell had three children, but continued to dedicate much of her time to her research and work. In 1991, Campbell's husband was offered the chair of anatomy at the University of Queensland, so the couple had moved once more.
In 1968, Campbell attended the University of New South Wales, where she graduated as an honor student with a bachelor's degree in science in physiology. [8] [9] In 1973, she received her doctorate degree in neurology from the University of Melbourne. [8]
Campbell's postdoctoral experience extends from working at the University of Melbourne (1973–75), University College London (1976), the University of Iowa (1977) and the University of Washington (1977–78). During this period, she researched the biology of smooth muscle cells in normal artery walls of the human body. She recognised the importance of her findings for treating arteries affected by Atherosclerosis. [3] [10]
In 1978, when Campbell returned to Australia, she was employed by the Baker Medical Research Institute in Melbourne. From this period, she obtained the career position as a senior research officer at the institution (1978–80) and Principal Research Fellow (1987-1991). [5] Her studies consolidated her early findings on vascular smooth muscle biology. [10]
In 1991, she left her position as the principal research fellow (1987–91) at the Baker Medical Research Institute. Campbell moved to Brisbane and became the founding director of the Centre for Research in Vascular Biology at the University of Queensland. With her experience, she obtained the career position as the principal research fellow in the Department of Anatomical Sciences (1991–94). [5] She became the inaugural president of the Australian Vascular Biology Society in Institute at the Wesley Hospital in 1996. [5]
Today, Campbell continues her work that ultimately began back in the early 1980s. Both Campbell and her husband began their work by looking at the origin of Myofibroblasts, which form as part of the inflammatory response to a wound. They noticed that these Myofibroblasts resembled the cells that form arteries, and hoped to eventually use this knowledge to grow artificial arteries and vessels. Campbell has been developing a technique to grown the artificial blood vessel in the body cavity of the person it will be implanted in, to reduce the risk of rejection. [11] In 1992, Campbell founded the Australian Vascular Biology Society, which she cites as the achievement she is most proud of. Additionally, she is the current chair of the Queensland Fellows of the Australian Academy of Science, and a member of the council.
Campbell has won worldwide acclaim for her ground-breaking research into the development of blood vessels naturally within a patient. [8] This process is undergoing pre-clinical trials in humans and may be used to treat patients suffering coronary heart disease, renal failure and other life-threatening conditions. This ‘Grow Your Own Arteries’ technique is helping patients survive coronary heart disease, renal failure and other life-threatening conditions. [8] [10]
Campbell was awarded the Wellcome Australia Medal for Medical and Scientific Research. During this year, she has obtained the position as Senior Principal Research Fellow at the National Health and Medical Research Council (NHMRC), and she was also a research professor at the University of Queensland. [3]
In the 2006 Queen's Birthday Honours Campbell was appointed Officer of the Order of Australia (AO) for "service to science and to medical research, particularly in the area of cell biology of coronary artery and other vascular diseases, and to education". [12]
Campbell is currently: [8] [7] [3]
Her main career is the director of the Australian Institute for Bioengineering and Nanotechnology (AIBN) for the University of Queensland.
Campbell has been awarded: [7] [10] [8] [14]
George Nikov Chaldakov born February 23, 1940, in Burgas, Bulgaria, is a Bulgarian vascular biologist well known for his contributions to the study of secretory function of vascular smooth muscle cells, and the role of neurotrophins and perivascular adipose tissue in pathogenesis of atherosclerosis. He published the first Bulgarian textbook of Cell Biology in 1996 and in 2005 founded the Bulgarian Society for Cell Biology.
Elizabeth Nabel is an American cardiologist and Executive Vice President of Strategy at ModeX Therapeutics and OPKO Health. Prior to this role, she served as President of Brigham Health and its Brigham and Women's Hospital, Professor of Medicine at Harvard Medical School, and Director of the NIH's National Heart, Lung, and Blood Institute.
Annette Jane Dobson is a Professor of Biostatistics in the University of Queensland's Australian Women and Girl's Health Research (AWaGHR) Centre in the School of Public Health. Dobson was Director of the Australian Longitudinal Study on Women's Health from 1995 to 2013. She is a highly cited publication author, a book author, and has received an Australia Day award.
Helen Blau is a cell biologist and stem cell researcher famous for her work on muscle diseases, regeneration and aging. She is the Donald E. and Delia B. Baxter Foundation Professor and the Director of the Baxter Laboratory for Stem Cell Biology at Stanford University. Blau is known for overturning the prevailing view that once a cell assumes a certain specialty in the body — or differentiated state —such as a skin or liver cell, it cannot be changed. Her research established that the fate of mammalian cells can be altered. Her finding that specialized cells can be triggered to turn on genetic programs characteristic of other differentiated states provided early evidence that mammalian cellular reprogramming was possible and opened the door to the use of reprogramming in stem cell biology. Her work set the stage for the development of induced pluripotent stem cells and associated stem cell therapies.
Katharina Gaus was a German-Australian immunologist and molecular microscopist. She was an NHMRC Senior Research Fellow and founding head of the Cellular Membrane Biology Lab, part of the Centre for Vascular Research at the University of New South Wales. Gaus used new super-resolution fluorescence microscopes to examine the plasma membrane within intact living cells, and study cell signalling at the level of single molecules to better understand how cells "make decisions". A key discovery of Gaus and her team was how T-cells decide to switch on the body's immune system to attack diseases. Her work is of importance to the development of drugs that can work with T-cells in support of the immune system.
Professor Jennifer Louise "Jenny" Martin is an Australian scientist and academic. She was the Deputy Vice-Chancellor at the University of Wollongong, in New South Wales from 2019-2022. She is a former director of the Griffith Institute for Drug Discovery at Griffith University. and a former Australian Research Council Laureate Fellow at the Institute for Molecular Bioscience, University of Queensland. Martin is Professor Emerita at the University of Queensland and adjunct professor at Griffith University. Her research expertise encompasses structural biology, protein crystallography, protein interactions and their applications in drug design and discovery.
Mollie Elizabeth Holman was an Australian physiologist whose work focused on muscles and the central nervous system.
Jennifer Lea Stow is deputy director (research), NHMRC Principal Research Fellow and head of the Protein Trafficking and Inflammation laboratory at the Institute for Molecular Bioscience (IMB), The University of Queensland, Australia. She received a PhD from Monash University in Melbourne in 1982, postdoctoral training at Yale University School of Medicine (US) in the Department of Cell Biology. Her first faculty position was as an assistant professor at Harvard University in the Renal Unit, Departments of Medicine and Pathology at the Massachusetts General Hospital in Boston.
Elizabeth Nesta "Pat" Marks was an Australian entomologist who described 38 new mosquito species, as well as new species of fruit flies, bugs, cockroaches and ticks. She had a PhD in insect physiology from the University of Cambridge and was a member of the Royal Entomological Society of London.
Elizabeth Morris Exley was an entomologist who researched Australian native bees particularly those in the subfamily Euryglossinae.
Mary Jean Garson is an organic chemist and academic in Australia. She currently works for the University of Queensland.
Annalisa Pastore is a Professor of Chemistry and Molecular Biology at King's College London. In 2018 she was appointed full professor at the Scuola Normale Superiore di Pisa. In 2022, she was appointed director of research for life sciences, chemistry and soft matter science at European Synchrotron Radiation Facility. She resigned in Frebruary 2023.
Kerrie Ann Wilson is an Australian environmental scientist who is the Queensland Chief Scientist and a Professor in the Faculty of Science at Queensland University of Technology (QUT). She was formerly the Pro Vice-Chancellor at QUT. Wilson is also an affiliated professor in conservation science at the University of Copenhagen, honorary professor at The University of Queensland, a member of the Australian Heritage Council and the Australian Natural Sciences Commissioner for UNESCO.
Alison Marion Gurney is professor of Pharmacology at the University of Manchester. She previously held the W.C. Bowman Chair of Pharmacology at the University of Strathclyde, where she was the first female appointed to a science professorship and the first female Professor of Pharmacology in Scotland. She is known for her research into the pharmacology and physiological roles of ion channels, especially in the pulmonary circulation.
Carol Shoshkes Reiss, an American viral immunologist, was a professor at New York University's Department of Biology between 1991 and 2020. She is currently a professor emerita at New York University. Her research focused on the dynamic contest between the mouse immune system and virus replication during central nervous system infection. Reiss was editor-in-chief of the journal Viral Immunology (2000–2006) and is currently editor-in-chief of the journal DNA and Cell Biology (2012–present).
Sarah K. England is a physiologist and biophysicist and the Alan A. and Edith L. Wolff Professor of Obstetrics and Gynaecology at Washington University School of Medicine. England conducts research on cation channels in uterine smooth muscle to understand the biological correlates of preterm birth and is the Associate Program Director of the Prematurity Research Center at Washington University as well as the Vice Chair of Research for the Center for Reproductive Health Sciences. In 2005, England was selected as a Robert Wood Johnson Foundation Health Policy Fellow in the Office of Senator Hillary Clinton where she used her scientific expertise in obstetrics and gynaecology to guide policy changes.
Robert Michael Graham is an Australian-born clinician-scientist. He is the Des Renford Professor of Medicine at University of New South Wales and the Head of the Molecular Cardiology and Biophysics Division at Victor Chang Cardiac Research Institute.
Fabienne Mackay is a French Australian research immunologist and institutional leader within the Australian medical research, education and innovation sectors. She is the Director and CEO of the QIMR Berghofer Medical Research Institute since 2020, after being the inaugural Head of the School of Biomedical Sciences at the University of Melbourne during the preceding five years. She is also an Honorary Professor at the Faculties of Medicine of the University of Queensland and the University of Melbourne. Her work has attracted public attention for its contribution to the pathophysiological understanding and treatment of lupus and other autoimmune diseases. Mackay has been notably awarded, achieving international reputation for her widely cited research describing B-cell activating factor (BAFF) and other cytokines of the TNF receptor superfamily, and their roles in B cell physiology, autoimmunity and cancer. She is an elected Fellow of the Australian Academy of Health and Medical Sciences.
Olga Ornatsky is a Soviet born, Canadian scientist. Ornatsky co-founded DVS Sciences in 2004 along with Dmitry Bandura, Vladimir Baranov and Scott D. Tanner.
Robert G. Parton FAA is a British/Australian cell biologist. He is a Group Leader in the Institute for Molecular Bioscience, University of Queensland and Deputy Director of the University of Queensland Centre for Microscopy and Microanalysis.
{{cite web}}
: CS1 maint: numeric names: authors list (link)